EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The lichen secondary metabolite lichesterinic acid exhibits antibiofilm activity against fungal pathogens

Martin N Odabas, Katharina Kainz, Ingo Weinberger, Kerstin Schloffer, Sabrina Riedl, Marylène Chollet-Krugler, Dagmar Zweytick, Joël Boustie, Frank Madeo, Didac Carmona-Gutierrez

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2025.1730365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Martin N Odabas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Biofilms, Antifungal Agents, Candida albicans, Lichens. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Karl-Franzens-Universität Graz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lichens are well known for producing unique secondary metabolites, some of which have been shown to exhibit medically relevant bioactivities, including antimicrobial effects. With the increasing prevalence of fungal infections and the growing resistance to commonly used antimycotics, there is an urgent need for new antifungal agents, especially for aged and/or immunocompromised individuals. In this study, we screened a collection of lichen-derived metabolites for antifungal properties in two medically relevant fungal pathogens, Candida albicans and Nakaseomyces glabratus . Several compounds exhibited inhibitory effects against planktonic cells and/or biofilm formation in at least one of these species. Notably, two related paraconic acids demonstrated the strongest activity against biofilms, structures that contribute significantly to antifungal resistance. Among them, lichesterinic acid was the most effective in disrupting pre-formed biofilms and preventing biofilm formation, key challenges in clinical mycology. Importantly, lichesterinic acid showed moderate tolerability in human cells. Furthermore, lichesterinic acid displayed antifungal efficacy in an in vivo model of fungal infection, supporting its potential for therapeutic development. These findings highlight lichen-derived metabolites, particularly paraconic acids, as promising candidates for new antifungal therapies targeting resistant and biofilm-associated fungal infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsAntifungal AgentsCandida albicansLichensHumansMicrobial Sensitivity TestsAnimalsSecondary Metabolism

Stichwörter der Autor:innen

Candida albicansCandida glabrataantimycoticsbiofilm eradicationbiofilm inhibitiondrugresistanceyeast

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria.
  • BioHealth Graz, Graz, Austria.
  • BioTechMed Graz, Graz, Austria.
  • CNRS, Institut des Sciences Chimiques de Rennes-UMR 6226, Univ Rennes, Rennes, France.

Förderung

  • Austrian Science Fund
  • Karl-Franzens-Universität Graz

Zitieren

APA

Odabas, M. N., Kainz, K., Weinberger, I., Schloffer, K., Riedl, S., Chollet-Krugler, M., Zweytick, D., Boustie, J., Madeo, F., & Carmona-Gutierrez, D. (2026). The lichen secondary metabolite lichesterinic acid exhibits antibiofilm activity against fungal pathogens. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1730365

Vancouver

Odabas MN, Kainz K, Weinberger I, Schloffer K, Riedl S, Chollet-Krugler M, et al. The lichen secondary metabolite lichesterinic acid exhibits antibiofilm activity against fungal pathogens. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2025.1730365

BibTeX
@article{Odabas2026,
  author = {Odabas, Martin N and Kainz, Katharina and Weinberger, Ingo and Schloffer, Kerstin and Riedl, Sabrina and Chollet-Krugler, Marylène and Zweytick, Dagmar and Boustie, Joël and Madeo, Frank and Carmona-Gutierrez, Didac},
  title = {The lichen secondary metabolite lichesterinic acid exhibits antibiofilm activity against fungal pathogens},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2025.1730365}
}
Kostenlos starten →